Abstract:BACKGROUND:Osteoblast-specific secreted osteocalcin has been considered as an important regulator of energy and glucose metabolism, however, the causative role and clinical potential of osteocalcin implicated in insulin resistance remains not fully understood.METHODS:Osteocalcin was administered intermittently in vivo and in vitro, and metabolic parameters, autophagy and insulin signaling were assessed.RESULTS:The intermittent injections of osteocalcin in mice fed high-fat diet resulted in decreased body weight gain, fat-pad weight gain, serum triglycerides, serum-free fatty acid, blood glucose, insulin level and partial normalization of glucose tolerance relative to the mice fed high-fat diet and received vehicle injections. Meanwhile, the intermittent administration of osteocalcin not only led to the alleviation of autophagic dysfunction and endoplasmic reticulum (ER) stress, but also contributed to the restoration of the impaired insulin signaling in adipose tissue and skeleton muscle of mice consumed the high-fat diet. In accordance with these findings in vivo, osteocalcin treatment also displayed a protective impact on adipocytes and myocytes against tunicamycin- or palmitate-induced ER stress and autophagy dysfunction in an XBP-1-independent manner, with these effects of osteocalcin being reversed by inhibition of mammalian target of rapamycin (mTOR) or nuclear factor-κB (NF-κB).CONCLUSIONS:Intermittent administration of osteocalcin efficiently reversed the attenuated autophagy and ER stress, and restored the impaired insulin sensitivity in cellular and mice models of insulin resistance. Our findings provide new insights into the clinical potential of osteocalcin in metabolic homeostasis, and suggest an innovative strategy for the treatment against diabetes, obesity and metabolic syndrome.

Research Progress in Osteocalcin for Regulation of Energy Metabolism

Research progress in regulation of glucose metabolism by osteocalcin

Osteopontin in Bone Metabolism and Bone Diseases

Research and Application of Target Therapy for Osteoporosis

The role of bone in energy metabolism: A focus on osteocalcin

Association of Osteocalcin with Body Fat and Metabolism of Glucose and Lipids

Focusing on Bone—new Means for the Management of Diabetes

Osteocalcin: Beyond Bones

Endocrine role of bone in the regulation of energy metabolism

Myokines: Metabolic Regulation in Obesity and Type 2 Diabetes

Osteocalcin Reverses Endoplasmic Reticulum Stress and Improves Impaired Insulin Sensitivity Secondary to Diet-Induced Obesity Through Nuclear Factor-κB Signaling Pathway

Role of osteocalcin in glucose metabolism

Interaction among Skeleton, Body Fat and Cardiovascular Diseases Mediated by Osteocalcin

Osteocalcin—A Versatile Bone-Derived Hormone

Autophagic Dysfunction is Improved by Intermittent Administration of Osteocalcin in Obese Mice.

Osteocalcin and Metabolic Syndrome

Osteocalcin: A bone protein with multiple endocrine functions

Relationship Between Osteocalcin and Atherosclerosis

The Role of Osteoclast Energy Metabolism in the Occurrence and Development of Osteoporosis

The regulatory role of AMPK signaling pathway in bone metabolism

The Roles of Epigenetics Regulation in Bone Metabolism and Osteoporosis